€28.16
0.57% day before yesterday
Amsterdam, Jan 02, 05:35 pm CET
ISIN
BE0003818359
Symbol
GLPG

Galapagos Stock price

€28.16
+1.32 4.92% 1M
+3.78 15.50% 6M
+0.16 0.57% YTD
+0.70 2.55% 1Y
-13.15 31.83% 3Y
-52.84 65.23% 5Y
-27.49 49.40% 10Y
+18.92 204.76% 20Y
Amsterdam, Closing price Fri, Jan 02 2026
+0.16 0.57%
ISIN
BE0003818359
Symbol
GLPG
Industry

Key metrics

Basic
Market capitalization
€1.8b
Enterprise Value
€-1.2b
Net debt
positive
Cash
€3.1b
Shares outstanding
66.0m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
6.4 | 6.6
EV/Sales
negative | negative
EV/FCF
4.2
P/B
0.8
Financial Health
Equity Ratio
70.0%
Return on Equity
2.6%
ROCE
-10.2%
ROIC
-
Debt/Equity
0.0
Financials (TTM | estimate)
Revenue
€286.8m | €280.5m
EBITDA
- | €-272.7m
EBIT
€-320.0m | €-341.5m
Net Income
€-436.0m | €-326.1m
Free Cash Flow
€-287.0m
Growth (TTM | estimate)
Revenue
-43.1% | 1.8%
EBITDA
- | -162.2%
EBIT
-49.8% | -123.2%
Net Income
-267.1% | -540.6%
Free Cash Flow
30.3%
Margin (TTM | estimate)
Gross
84.1%
EBITDA
- | -97.2%
EBIT
-111.6%
Net
-152.0% | -116.2%
Free Cash Flow
-100.1%
More
EPS
€-6.6
FCF per Share
€-4.3
Short interest
-
Employees
704
Rev per Employee
€390.0k
Show more

Is Galapagos a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,082 stocks worldwide.

Galapagos Stock Analysis

Unlock Scores for Free

Analyst Opinions

19 Analysts have issued a Galapagos forecast:

3x Buy
16%
6x Hold
32%
10x Sell
53%

Analyst Opinions

19 Analysts have issued a Galapagos forecast:

Buy
16%
Hold
32%
Sell
53%

Financial data from Galapagos

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '25
+/-
%
287 287
43% 43%
100%
- Direct Costs 46 46
139% 139%
16%
241 241
22% 22%
84%
- Selling and Administrative Expenses 151 151
19% 19%
53%
- Research and Development Expense - -
-
-
- -
-
-
- Depreciation and Amortization - -
-
-
EBIT (Operating Income) EBIT -320 -320
50% 50%
-112%
Net Profit -436 -436
267% 267%
-152%

In millions EUR.

Don't miss a Thing! We will send you all news about Galapagos directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Galapagos Stock News

Positive
Seeking Alpha
12 days ago
Galapagos now presents a deep value opportunity, underpinned by a €3B cash reserve and a decisive shift to capital allocation discipline. GLPG's restructuring—discontinuing cell therapy, slashing headcount, and targeting cash flow neutrality by YE2026—positions it as a streamlined M&A platform. Management's M&A-focused pedigree, led by ex-AbbVie dealmakers, signals a pivot from pipeline relianc...
Neutral
GlobeNewsWire
26 days ago
High complete response rates and minimal residual disease (MRD) negativity, with durable responses, in high-risk mantle cell lymphoma (MCL) with GLPG5101, a fresh, early memory-enriched CAR T-cell therapy with a 7-day vein-to-vein time
Neutral
GlobeNewsWire
about one month ago
Mechelen, Belgium ; November 26, 2025, 07:30 CET; regulated information – Galapagos NV (Euronext & NASDAQ: GLPG) received transparency notifications from Bank of America.
More Galapagos News

Company Profile

Galapagos NV is a biotechnology company, which engages in the identification and development of small molecule and antibody therapies. It operates through the Research & Development and Fee-for-Services segment. The company was founded by Onno van de Stolpe, Rudi Pauwels, and Helmuth van Es on June 30, 1999 and is headquartered in Mechelen, Belgium.

Head office Belgium
CEO Henry Gosebruch
Employees 704
Founded 1999
Website www.glpg.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today